Björk D, Carling U, Gilg S, Hasselgren K, Larsen PN, Lindell G, Røsok BI, Sandström P, Sturesson C, Tschuor C, Sparrelid E, Björnsson B(2025) Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort study Eur J Surg Oncol, 51(7), 109995(in press) DOI 10.1016/j.ejso.2025.109995, PubMed 40147207
Carling U(2025) Comment on Radiation Lobectomy in Adjunct to Double Vein Embolization to Reach Sufficient Future Liver Remnant in Patients with Colorectal Cancer Liver Metastases: A Case Series Cardiovasc Intervent Radiol, 48(3), 386-387 DOI 10.1007/s00270-025-03975-2, PubMed 39984670
Korenblik R, James S, Smits J, Díaz-Nieto R, Davis R, Chan BKY, Erdmann JI, Zijlstra IAJ, Arntz PJW, Kollmar O, Hoffmann MH, Vass DG, Lindsay R, Serenari M, Cappelli A, Gobardhan PD, Imani F, Suarez YF, Muños FG, Grünhagen DJ, Moelker A, Pieterman KJ, Kleeff J, Wohlgemuth WA, Herrero Eet al.(2025) Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial Lancet Reg Health Eur, 53, 101284 DOI 10.1016/j.lanepe.2025.101284, PubMed 40255933
